Clinicians must, therefore, extrapolate from established principles for GLP-1 switching namely, avoiding direct dose equivalence and prioritising patient safety as per individual drug summary of product characteristics
The first few weeks often show the most pronounced effects as your body adjusts to consistently elevated GH levels
Greater Weight Loss Clinical Trial Data: In the Phase 2 TRIUMPH-1 study , retatrutide achieved unprecedented levels of weight loss : Up to 24.2% average total body weight loss at 48 weeks Over 26% weight loss at the highest dose (12 mg weekly) In comparison: Tirzepatides weight loss peaked at about 22.5% in SURMOUNT-1 at 72 weeks This suggests faster, more significant fat loss in less time with retatrutide
Program Guidelines Follow the prescribed medication schedule Maintain recommended dietary changes Attend regular follow-up appointments Track progress and communicate with our team Who is an Ideal Candidate
It is available through compounding pharmacies and research chemical suppliers and exists in a regulatory gray area
Zwar formal nicht pathologisch, aber bereits als funktionelle Strung zu bewerten
